To further characterize the effect of these kinase inhibitors in preventing the TDP-43 cell-to-cell transmission, we performed different studies using CM from severe AD cases treated independently with the TTBK1 inhibitor VNG1.47 or CK1 inhibitor IGS2.7. The gene discussed is TARDBP; the disease is Alzheimer disease.